Multiple actions of the novel anticonvulsant drug topiramate in the rat subiculum in vitro

Brain Research

Volumn 807, Issue 1-2, 1998, Pages 125-134

  Kawasaki, Hiroto ^a   Tancredi, Virginia ^b   D'Arcangelo, Giovanna ^b   Avoli, Massimo ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

GABA; Na+ electrogenesis; Rat; Subiculum; Topiramate

Indexed keywords

TOPIRAMATE;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; DRUG EFFECT; GRANULE CELL; HYPERPOLARIZATION; INTRACELLULAR RECORDING; MEMBRANE DEPOLARIZATION; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM CURRENT; SUBICULUM; VOLTAGE CLAMP;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; DRUG EVALUATION, PRECLINICAL; FRUCTOSE; HIPPOCAMPUS; ION CHANNEL GATING; MALE; MEMBRANE POTENTIALS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

EID: 0032487644     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00785-9     Document Type: Article

References (22)

1. Avoli M., Lopantsev V. Topiramate blocks ictal-like discharges in the entorhinal cortex. Epilepsia. 38(S8):1997;44.
2. Brown S.D., Wolf H.H., Swinyard E.A., Twyman R.E., White H.S. The novel anticonvulsant topiramate enhances GABA-mediated chloride flux. Epilepsia. 34(S5):1993;123-124.
3. Coulter D.A., Sombati S., DeLorenzo R.J. Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons. Epilepsia. 34(S5):1993;123.
4. Coulter D.A., Sombati S., DeLorenzo R.J. Topiramate effects on excitatory amino acid mediated responses in cultured hippocampal neurons: selective blockade of kainate currents. Epilepsia. 36(S4):1995;40.
5. W.E. Crill, P.C. Schwindt, W.J. Spain, Membrane properties of cat Betz cells studied in vitro, in: M. Avoli, P. Gloor, G. Kostopoulos, R. Naquet (Eds.), Generalized Epilepsy: Neurobiological Approaches, Birkhäuser, Boston, 1990, pp. 51-60.
6. Edmonds H.L. Jr., Jiang Y.D., Zhang P.Y., Shank R.P. Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy. Life Sciences. 59:1996;127-131.
7. + currents. Neurosci. Lett. 231:1997;13-16.
8. Kawasaki H., Lopantsev V., Tancredi V., Avoli M. Multiple actions of topiramate on rat subicular bursting neurons. Epilepsia. 38(S8):1997;98.
9. Lopes da Silva F.H., Witter M.P., Boeijinga P.H., Lohman H.M. Anatomic organization and physiology of the limbic cortex. Physiol. Rev. 70:1990;453-511.
10. R.L. Macdonald, M.J. McLean, Anticonvulsant drugs: mechanisms of action, in: A.V. Delgado-Escueta, A.A. Ward Jr., D.M. Woodbury, R.J. Porter (Eds.), Advances in Neurology, Raven Press, New York, 1986, pp. 713-736.
11. Mattia D., Hwa G.G.C., Avoli M. Membrane properties of rat subicular neurons in vitro. J. Neurophysiol. 70:1993;1244-1248.
12. Mattia D., Kawasaki H., Avoli M. In vitro electrophysiology of rat subicular bursting neurons. Hippocampus. 7:1997;48-57.
13. Mattia D., Kawasaki H., Avoli M. Repetitive firing and oscillatory activity of pyramidal-like bursting neurones in the rat subiculum. Exp. Brain Res. 114:1997;507-517.
14. Nakamura J., Tamura S., Kanda T., Ishii A., Ishihara K., Serikawa T., Yamada J., Sasa M. Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice. Eur. J. Pharmacol. 254:1994;83-89.
15. Ragsdale D.S., Avoli M. Sodium channels as molecular targets for antiepileptic drugs. Brain Res. Rev. 26:1998;16-28.
16. Sachdeo R.C., Sachdeo S.K., Walker S.A., Kramer L.D., Nayak R.K., Doose D.R. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia. 37:1996;774-780.
17. Shank R.P., Gardocki J.F., Vaught J.L., Davis C.B., Schupsky J.J., Raffa R.B., Dodgson S.J., Nortey S.O., Maryanoff B.E. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia. 35:1994;450-460.
18. Tassinari C.A., Michelucci R., Chauvel P., Chodkiewicz J.P., Shorvon S.D., Henriksen O., Dam M., Reife R., Pledger G., Karim R. Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia. 37:1996;763-768.
19. Wauquier A., Zhou S. Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Res. 24:1996;73-77.
20. White H.S., Brown S.D., Skeen G.A., Twyman R.E. The investigational anticonvulsant topiramate potentiates GABA-evoked currents in mouse cortical neurons. Epilepsia. 36(S4):1995.
21. White H.S., Brown S.D., Woodhead J.H., Skeen G.A., Wolf H.H. Topiramate enhances GABA-mediated chloride flux and GABA-evoked currents in mouse brain neurons and increases seizure threshold. Epilepsy Res. 28:1997;167-179.
22. Zona C., Ciotti M.T., Avoli M. Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells. Neurosci. Lett. 231:1997;123-126.